Identifying Optimal Methods for Addressing Confounding Bias When Estimating the Effects of State-level Policies

Background: Policy evaluation studies that assess how state-level policies affect health-related outcomes are foundational to health and social policy research. The relative ability of newer analytic methods to address confounding, a key source of bias in observational studies, has not been closely examined. Methods: We conducted a simulation study to examine how differing magnitudes of confounding affected the performance of four methods used for policy evaluations: (1) the two-way fixed effects (TWFE) difference-in-differences (DID) model; (2) a one-period lagged autoregressive (AR) model; (3) augmented synthetic control method (ASCM); and (4) the doubly robust DID approach with multiple time periods from Callaway-Sant'Anna (CSA). We simulated our data to have staggered policy adoption and multiple confounding scenarios (i.e., varying the magnitude and nature of confounding relationships). Results: Bias increased for each method: (1) as confounding magnitude increases; (2) when confounding is generated with respect to prior outcome trends (rather than levels), and (3) when confounding associations are nonlinear (rather than linear). The AR and ASCM have notably lower root mean squared error than the TWFE model and CSA approach for all scenarios; the exception is nonlinear confounding by prior trends, where CSA excels. Coverage rates are unreasonably high for ASCM (e.g., 100%), reflecting large model-based standard errors and wide confidence intervals in practice. Conclusions: Our simulation study indicated that no single method consistently outperforms the others. But a researcher's toolkit should include all methodological options. Our simulations and associated R package can help researchers choose the most appropriate approach for their data.

[1]  Anne E. Boustead,et al.  Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond. , 2021, JAMA health forum.

[2]  C. Kurz Augmented Inverse Probability Weighting and the Double Robustness Property , 2021, Medical decision making : an international journal of the Society for Medical Decision Making.

[3]  Joseph D. Pane,et al.  Methodological considerations for estimating policy effects in the context of co-occurring policies , 2021, Health Services and Outcomes Research Methodology.

[4]  Avi Feller,et al.  Synthetic controls with staggered adoption , 2021, Journal of the Royal Statistical Society: Series B (Statistical Methodology).

[5]  Kara E. Rudolph,et al.  When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws. , 2021, Epidemiology.

[6]  Megan S. Schuler,et al.  Methodological challenges and proposed solutions for evaluating opioid policy effectiveness , 2020, Health Services and Outcomes Research Methodology.

[7]  E. C. Matthay,et al.  Analytic methods for estimating the health effects of social policies in the presence of simultaneous change in multiple policies: A review , 2020, medRxiv.

[8]  Ellicott C. Matthay,et al.  The revolution will be hard to evaluate: How simultaneous change in multiple policies affects policy-based health research , 2020, medRxiv.

[9]  Beth Ann Griffin,et al.  The state of the science in opioid policy research. , 2020, Drug and Alcohol Dependence.

[10]  C. Davis,et al.  Opioid Policy Changes During the COVID-19 Pandemic - and Beyond , 2020, Journal of addiction medicine.

[11]  Nathan Chan,et al.  The Effects of Recreational Marijuana Legalization and Dispensing on Opioid Mortality , 2020, Economic Inquiry.

[12]  Terry L. Schell,et al.  Moving beyond the classic difference-in-differences model: a simulation study comparing statistical methods for estimating effectiveness of state-level policies , 2020, BMC Medical Research Methodology.

[13]  P. Burstein The Determinants of Public Policy: What Matters and How Much , 2020 .

[14]  Laura A. Hatfield,et al.  Confounding and regression adjustment in difference‐in‐differences studies , 2019, Health services research.

[15]  David Powell,et al.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. , 2019, JAMA internal medicine.

[16]  Pedro H. C. Sant'Anna,et al.  Doubly Robust Difference-in-Differences Estimators , 2018, Journal of Econometrics.

[17]  Avi Feller,et al.  The Augmented Synthetic Control Method , 2018, Journal of the American Statistical Association.

[18]  C. Borrell,et al.  Towards a policy relevant neighborhoods and health agenda: engaging citizens, researchers, policy makers and public health professionals. SESPAS Report 2018. , 2018, Gaceta sanitaria.

[19]  Coady Wing,et al.  Designing Difference in Difference Studies: Best Practices for Public Health Policy Research. , 2018, Annual review of public health.

[20]  Pedro H. C. Sant'Anna,et al.  Difference-in-Differences with Multiple Time Periods , 2018, Journal of Econometrics.

[21]  Xavier d'Haultfoeuille,et al.  Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects , 2018, American Economic Review.

[22]  Laura A. Hatfield,et al.  Matching and Regression to the Mean in Difference‐in‐Differences Analysis , 2017, Health services research.

[23]  Angela Kilby,et al.  Opioids for the Masses: Welfare Tradeoffs in the Regulation of Narcotic Pain Medications , 2016 .

[24]  Andrew M Ryan,et al.  Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences. , 2015, Health services research.

[25]  M. J. Laan,et al.  Targeted Learning: Causal Inference for Observational and Experimental Data , 2011 .

[26]  Joshua D. Angrist,et al.  Mostly Harmless Econometrics: An Empiricist's Companion , 2008 .

[27]  M. Robins James,et al.  Estimation of the causal effects of time-varying exposures , 2008 .

[28]  M. J. van der Laan,et al.  The International Journal of Biostatistics Targeted Maximum Likelihood Learning , 2011 .

[29]  J. Robins,et al.  Estimating causal effects from epidemiological data , 2006, Journal of Epidemiology and Community Health.

[30]  Maia Berkane Latent Variable Modeling and Applications to Causality , 1997 .

[31]  P. Rosenbaum The Consequences of Adjustment for a Concomitant Variable that Has Been Affected by the Treatment , 1984 .

[32]  Beth Ann Griffin,et al.  Evaluating Methods to Estimate the Effect of State Laws on Firearm Deaths , 2018 .

[33]  James M. Robins,et al.  Causal Inference from Complex Longitudinal Data , 1997 .

[34]  J. Robins A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .